117 GENES FOUNDi

Show / hide columns »

XML | RDF | TAB | « prev | Page of 3 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

Subcellular location

x

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GNRHRGonadotropin-releasing hormone receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
IFNAR1Interferon (alpha, beta and omega) receptor 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
CytosolExpressed in all
IFNAR2Interferon (alpha, beta and omega) receptor 2Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
IFNGR1Interferon gamma receptor 1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Endoplasmic reticulum
Vesicles
Plasma membrane
Expressed in all
IFNGR2Interferon gamma receptor 2 (interferon gamma transducer 1)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Nucleoplasm
Golgi apparatus
Mixed
IGF1RInsulin-like growth factor 1 receptorCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
VesiclesMixed
IL11RAInterleukin 11 receptor, alphaDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IL17AInterleukin 17ACancer-related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
IL1BInterleukin 1, betaCancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enhanced
IL1R1Interleukin 1 receptor, type ICancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
VesiclesExpressed in all
IL2RAInterleukin 2 receptor, alphaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
IL2RBInterleukin 2 receptor, betaCancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
IL2RGInterleukin 2 receptor, gammaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
VesiclesTissue enhanced
IL3RAInterleukin 3 receptor, alpha (low affinity)CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IL5Interleukin 5Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
IL6Interleukin 6Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enhanced
IL6RInterleukin 6 receptorCancer-related genes
Candidate cardiovascular disease genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
INSRInsulin receptorCD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
VesiclesExpressed in all
ITGA2BIntegrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)Cancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Cell Junctions
Cytosol
Tissue enhanced
ITGA4Integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Tissue enhanced
ITGALIntegrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ITGAVIntegrin, alpha VCancer-related genes
CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Focal adhesion sites
Cytosol
Expressed in all
ITGB1Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Endoplasmic reticulum
Plasma membrane
Focal adhesion sites
Expressed in all
ITGB3Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ITGB7Integrin, beta 7Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Mixed
KDRKinase insert domain receptorCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Plasma membraneTissue enhanced
LEPRLeptin receptorCancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
VesiclesMixed
LHCGRLuteinizing hormone/choriogonadotropin receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Group enriched
M6PRMannose-6-phosphate receptor (cation dependent)FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
MC2RMelanocortin 2 receptor (adrenocorticotropic hormone)Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
MPLMPL proto-oncogene, thrombopoietin receptorCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Plasma membraneTissue enhanced
MR1Major histocompatibility complex, class I-relatedFDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneMixed
MS4A1Membrane-spanning 4-domains, subfamily A, member 1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
MS4A2Membrane-spanning 4-domains, subfamily A, member 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
OXTROxytocin receptorFDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
PCSK9Proprotein convertase subtilisin/kexin type 9Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
PDCD1Programmed cell death 1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
PDGFRBPlatelet-derived growth factor receptor, beta polypeptideCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Vesicles
Cytosol
Mixed
PGFPlacental growth factorCancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
RAS pathway related proteins
Nucleoplasm
Mitochondria
Cytosol
Tissue enhanced
PLATPlasminogen activator, tissueCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Actin filamentsTissue enhanced
PLAUPlasminogen activator, urokinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Expressed in all
PLAURPlasminogen activator, urokinase receptorCancer-related genes
CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneExpressed in all
PLGPlasminogenCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
VesiclesTissue enriched
PLIN3Perilipin 3FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Lipid droplets
Cytosol
Expressed in all
PRLRProlactin receptorDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PTH2RParathyroid hormone 2 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
RAMP1Receptor (G protein-coupled) activity modifying protein 1FDA approved drug targets
Predicted membrane proteins
Nucleoplasm
Nuclear membrane
Tissue enhanced
RAMP2Receptor (G protein-coupled) activity modifying protein 2FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesMixed
RAMP3Receptor (G protein-coupled) activity modifying protein 3FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
SCTRSecretin receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced

« prev | Page of 3 | next »